Zevra Therapeutics, Inc. (ZVRA) Net income 2016–2025
Zevra Therapeutics, Inc. (ZVRA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$83.2MFY2025 · since FY2016: -$16.5M → $83.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $83.2M | +178.9% |
| FY2024 | -$105.5M | -129.1% |
| FY2023 | -$46.0M | -72.0% |
| FY2022 | -$26.8M | -212.9% |
| FY2021 | -$8.6M | +33.0% |
| FY2020 | -$12.8M | +48.0% |
| FY2019 | -$24.5M | +56.6% |
| FY2018 | -$56.5M | -30.1% |
| FY2017 | -$43.4M | -162.7% |
| FY2016 | -$16.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice